Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_C2,1 | Lung | Primary cancer | 2,758 | Tumor/Malignant | 57.2% | 0.96 | 0.10 |
| NSCLC_38242124__IMC__88_C2,10 | Lung | Primary cancer | 3,307 | Tumor/Malignant | 35.1% | 0.94 | 0.22 |
| NSCLC_38242124__IMC__88_C2,11 | Lung | Primary cancer | 1,306 | Stromal | 31.2% | 0.81 | 0.53 |
| NSCLC_38242124__IMC__88_C2,12 | Lung | Primary cancer | 3,372 | Tumor/Malignant | 36.8% | 0.96 | 0.14 |
| NSCLC_38242124__IMC__88_C2,13 | Lung | Primary cancer | 1,907 | Tumor/Malignant | 49.6% | 0.95 | 0.17 |
| NSCLC_38242124__IMC__88_C2,14 | Lung | Primary cancer | 2,427 | Stromal | 30.0% | 0.80 | 0.46 |
| NSCLC_38242124__IMC__88_C2,15 | Lung | Primary cancer | 1,403 | Tumor/Malignant | 29.8% | 0.97 | 0.14 |
| NSCLC_38242124__IMC__88_C2,2 | Lung | Primary cancer | 5,346 | Immune | 63.3% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__88_C2,3 | Lung | Primary cancer | 3,214 | Tumor/Malignant | 26.1% | 0.92 | 0.24 |
| NSCLC_38242124__IMC__88_C2,6 | Lung | Primary cancer | 2,389 | Tumor/Malignant | 34.8% | 0.51 | 0.88 |
| NSCLC_38242124__IMC__88_C2,8 | Lung | Primary cancer | 3,538 | Stromal | 39.4% | 0.90 | 0.33 |
| NSCLC_38242124__IMC__88_C2,9 | Lung | Primary cancer | 2,497 | Tumor/Malignant | 32.0% | 0.95 | 0.23 |
| NSCLC_38242124__IMC__88_C3,1 | Lung | Primary cancer | 2,992 | Tumor/Malignant | 28.2% | 0.51 | 0.75 |
| NSCLC_38242124__IMC__88_C3,11 | Lung | Primary cancer | 2,885 | Tumor/Malignant | 54.9% | 0.93 | 0.22 |
| NSCLC_38242124__IMC__88_C3,12 | Lung | Primary cancer | 5,783 | Immune | 81.8% | 0.97 | 0.09 |
| NSCLC_38242124__IMC__88_C3,14 | Lung | Primary cancer | 4,881 | Immune | 93.0% | 0.99 | 0.02 |
| NSCLC_38242124__IMC__88_C3,15 | Lung | Primary cancer | 682 | Tumor/Malignant | 28.2% | 0.48 | 0.91 |
| NSCLC_38242124__IMC__88_C3,2 | Lung | Primary cancer | 1,570 | Stromal | 25.4% | 0.34 | 1.02 |
| NSCLC_38242124__IMC__88_C3,3 | Lung | Primary cancer | 383 | Tumor/Malignant | 42.8% | 0.89 | 0.20 |
| NSCLC_38242124__IMC__88_C3,4 | Lung | Primary cancer | 133 | Stromal | 56.4% | 0.64 | 0.65 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_C2,1 | Lung | Primary cancer | 2,758 | Tumor/Malignant | 57.2% | 0.96 | 0.10 |
| NSCLC_38242124__IMC__88_C2,10 | Lung | Primary cancer | 3,307 | Tumor/Malignant | 36.2% | 0.94 | 0.23 |
| NSCLC_38242124__IMC__88_C2,11 | Lung | Primary cancer | 1,306 | Stromal | 21.1% | 0.87 | 0.41 |
| NSCLC_38242124__IMC__88_C2,12 | Lung | Primary cancer | 3,372 | Tumor/Malignant | 36.9% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__88_C2,13 | Lung | Primary cancer | 1,907 | Tumor/Malignant | 46.1% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__88_C2,14 | Lung | Primary cancer | 2,427 | Stromal | 33.8% | 0.49 | 0.80 |
| NSCLC_38242124__IMC__88_C2,15 | Lung | Primary cancer | 1,403 | Tumor/Malignant | 30.3% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__88_C2,2 | Lung | Primary cancer | 5,346 | Lymphoid | 49.5% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__88_C2,3 | Lung | Primary cancer | 3,214 | Tumor/Malignant | 26.2% | 0.93 | 0.25 |
| NSCLC_38242124__IMC__88_C2,6 | Lung | Primary cancer | 2,389 | Tumor/Malignant | 29.1% | 0.52 | 0.89 |
| NSCLC_38242124__IMC__88_C2,8 | Lung | Primary cancer | 3,538 | Stromal | 37.7% | 0.91 | 0.31 |
| NSCLC_38242124__IMC__88_C2,9 | Lung | Primary cancer | 2,497 | Tumor/Malignant | 24.9% | 0.70 | 0.76 |
| NSCLC_38242124__IMC__88_C3,1 | Lung | Primary cancer | 2,992 | Tumor/Malignant | 25.6% | 0.52 | 0.74 |
| NSCLC_38242124__IMC__88_C3,11 | Lung | Primary cancer | 2,885 | Tumor/Malignant | 35.4% | 0.99 | 0.07 |
| NSCLC_38242124__IMC__88_C3,12 | Lung | Primary cancer | 5,783 | Myeloid | 70.3% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__88_C3,14 | Lung | Primary cancer | 4,881 | Lymphoid | 93.2% | 0.99 | 0.02 |
| NSCLC_38242124__IMC__88_C3,15 | Lung | Primary cancer | 682 | Tumor/Malignant | 26.5% | 0.48 | 0.92 |
| NSCLC_38242124__IMC__88_C3,2 | Lung | Primary cancer | 1,570 | Tumor/Malignant | 24.6% | 0.68 | 0.69 |
| NSCLC_38242124__IMC__88_C3,3 | Lung | Primary cancer | 383 | Stromal | 55.9% | 0.41 | 0.75 |
| NSCLC_38242124__IMC__88_C3,4 | Lung | Primary cancer | 133 | Stromal | 56.4% | 0.64 | 0.65 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_C2,1 | Lung | Primary cancer | 2,758 | Tumor/Malignant cell | 57.1% | 0.96 | 0.10 |
| NSCLC_38242124__IMC__88_C2,10 | Lung | Primary cancer | 3,307 | Tumor/Malignant cell | 44.8% | 0.91 | 0.35 |
| NSCLC_38242124__IMC__88_C2,11 | Lung | Primary cancer | 1,306 | Fibroblast | 28.2% | 0.65 | 0.78 |
| NSCLC_38242124__IMC__88_C2,12 | Lung | Primary cancer | 3,372 | Tumor/Malignant cell | 41.8% | 0.93 | 0.22 |
| NSCLC_38242124__IMC__88_C2,13 | Lung | Primary cancer | 1,907 | Tumor/Malignant cell | 50.3% | 0.95 | 0.17 |
| NSCLC_38242124__IMC__88_C2,14 | Lung | Primary cancer | 2,427 | Other | 26.7% | 0.61 | 0.75 |
| NSCLC_38242124__IMC__88_C2,15 | Lung | Primary cancer | 1,403 | Tumor/Malignant cell | 37.4% | 0.93 | 0.29 |
| NSCLC_38242124__IMC__88_C2,2 | Lung | Primary cancer | 5,346 | B cell | 34.6% | 0.78 | 0.50 |
| NSCLC_38242124__IMC__88_C2,3 | Lung | Primary cancer | 3,214 | Tumor/Malignant cell | 34.9% | 0.88 | 0.36 |
| NSCLC_38242124__IMC__88_C2,6 | Lung | Primary cancer | 2,389 | Tumor/Malignant cell | 37.5% | 0.89 | 0.41 |
| NSCLC_38242124__IMC__88_C2,8 | Lung | Primary cancer | 3,538 | Fibroblast | 40.3% | 0.85 | 0.43 |
| NSCLC_38242124__IMC__88_C2,9 | Lung | Primary cancer | 2,497 | Tumor/Malignant cell | 37.6% | 0.92 | 0.31 |
| NSCLC_38242124__IMC__88_C3,1 | Lung | Primary cancer | 2,992 | Tumor/Malignant cell | 42.2% | 0.75 | 0.55 |
| NSCLC_38242124__IMC__88_C3,11 | Lung | Primary cancer | 2,885 | Tumor/Malignant cell | 54.4% | 0.94 | 0.21 |
| NSCLC_38242124__IMC__88_C3,12 | Lung | Primary cancer | 5,783 | Granulocyte | 79.9% | 0.97 | 0.10 |
| NSCLC_38242124__IMC__88_C3,14 | Lung | Primary cancer | 4,881 | B cell | 64.1% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__88_C3,15 | Lung | Primary cancer | 682 | Other | 35.8% | 0.43 | 0.99 |
| NSCLC_38242124__IMC__88_C3,2 | Lung | Primary cancer | 1,570 | Fibroblast | 29.7% | 0.43 | 0.99 |
| NSCLC_38242124__IMC__88_C3,3 | Lung | Primary cancer | 383 | Fibroblast | 54.3% | 0.42 | 0.76 |
| NSCLC_38242124__IMC__88_C3,4 | Lung | Primary cancer | 133 | Fibroblast | 56.4% | 0.64 | 0.65 |